Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Clin Ter ; 172(2): 172-174, 2021 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-33763671

RESUMEN

ABSTRACT: SARS Cov 2 pandemic outbreak caused countless changes in the daily habits among people in the entire World. National Health Systems were highly stressed and at severe risk of collapse. In the first months of 2020, it was expected a worsening of the typical overcrowding working flow. Quite the opposite, we found out an unexpected decrease throughout the daily ED visits. We evaluated the ER visits of a University Metropolitan Hospital in Rome in March 2020, comparing them with the same month in 2019. We highlight the sharp decline in ED visits for deferrable urgencies, considered among the leading causes of ED overcrowding. On the contrary, the rate of visits for "time-dependent" pathologies is superimposable for those pathologies mainly centralized through the Out-of-Hospital Emergency System. In a historical period where significant outpatient activity restrictions took place, we expected an increase in ED visits for deferred emergencies. On the contrary, it was undergoing a considerable decrease. The critical decrease in accesses recorded in March 2020 can be considered an indicator of ED's improper use. Probably, the fear of a possible coronavirus-related infection might have to lead the population to refer to the ED just in case of real emergency condition or severe medical issues, as it should "normally" be. The critical decrease in accesses recorded in March 2020 can be considered an indicator of ED's improper use. We would highlight the need to sensitize people to proper use of Emergency Medical Services, avoiding overcrowding and overuse. This unexpected event, lead by a global pandemic, could help reorganize the whole Health System.


Asunto(s)
COVID-19/epidemiología , Servicios Médicos de Urgencia/estadística & datos numéricos , Servicio de Urgencia en Hospital/estadística & datos numéricos , Humanos , Pandemias
2.
Eur Rev Med Pharmacol Sci ; 24(22): 11919-11925, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-33275264

RESUMEN

OBJECTIVE: The pandemic from SARS-CoV-2 is having a profound impact on daily life of a large part of world population. Italy was the first Western country to impose a general lockdown to its citizens. Implications of these measures on several aspects of public health remain unknown. The aim of this study was to investigate the effects of the lockdown on surgical emergencies volumes and care in a large, tertiary referral center. MATERIALS AND METHODS: Electronic medical records of all patients visited in our Emergency Department (ED) and admitted in a surgical ward from February 21st 2020 to May 3rd 2020 were collected, analyzed and compared with the same periods of 2019 and 2018 and a cross-sectional study was performed. RESULTS: Number of surgical admissions dropped significantly in 2020 with respect to the same periods of 2019 and 2018, by almost 50%. The percentage distribution of admissions in different surgical wards did not change over the three years. Time from triage to operating room significantly reduced in 2020 respect to 2019 and 2018 (p<0.001). CONCLUSIONS: The lockdown in Italy due to SARS-CoV-2 pandemic arguably represents the largest social experiment in modern times. Data provided by our study provide useful information to health authorities and policymakers about the effects of activity restriction on surgical accesses and changing epidemiology due to an exceptional external event.


Asunto(s)
COVID-19 , Colecistitis Aguda/epidemiología , Enfermedades Gastrointestinales/epidemiología , Hospitalización/tendencias , Procedimientos Quirúrgicos Operativos/tendencias , Adulto , Apendicitis/epidemiología , Apendicitis/cirugía , Colecistitis Aguda/cirugía , Diverticulitis/epidemiología , Diverticulitis/cirugía , Urgencias Médicas , Servicio de Urgencia en Hospital , Femenino , Enfermedades Gastrointestinales/cirugía , Hemorragia Gastrointestinal/epidemiología , Hemorragia Gastrointestinal/cirugía , Hernia/epidemiología , Herniorrafia/tendencias , Humanos , Obstrucción Intestinal/epidemiología , Obstrucción Intestinal/cirugía , Perforación Intestinal/epidemiología , Perforación Intestinal/cirugía , Italia/epidemiología , Masculino , Persona de Mediana Edad , Enfermedades del Recto/epidemiología , Enfermedades del Recto/cirugía , Servicio de Cirugía en Hospital , Centros de Atención Terciaria , Tiempo de Tratamiento/tendencias
3.
Eur Rev Med Pharmacol Sci ; 23(17): 7517-7518, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31539140

RESUMEN

Capnocytophaga canimorsus is a Gram-negative rods frequently isolated as commensal in the saliva of pets that can be transmitted to humans. We report a case of septic shock caused by this pathogen. A 78-year-old man affected by diabetes and hypertension was admitted for fever in our Emergency Department. He reported fever (37.7°C) with normal values of blood pressure, heart rate and saturation of oxygen. Laboratory studies showed increased values of procalcitonin and normal white-cell level. Blood cultures were collected and an empirical antibiotic therapy was started. He reported six days earlier a bite of a dog at the right hand. During the following days the patient presented a deterioration of clinical conditions with fever, asthenia and comparison of petechial lesions. C. canimorsus was isolated from blood cultures. He was treated with fluids and appropriate antibiotic therapy with a full recovery. Dog wounds are frequent minor injuries with an underestimated worldwide incidence because only few patients develop complications. C. canimorsus could be an emerging cause of sepsis, also in immunocompetent patients. The current understanding of risk factors for C. canimorsus associated sepsis and a prompt approach to anamnesis and treatment of early stage injuries, could have a considerable medical outcome.


Asunto(s)
Antibacterianos/uso terapéutico , Capnocytophaga/aislamiento & purificación , Enfermedades de los Perros/microbiología , Infecciones por Bacterias Gramnegativas/diagnóstico , Choque Séptico/microbiología , Anciano , Animales , Comorbilidad , Perros , Infecciones por Bacterias Gramnegativas/sangre , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Humanos , Masculino , Choque Séptico/tratamiento farmacológico , Resultado del Tratamiento
4.
Eur Rev Med Pharmacol Sci ; 23(1): 426-430, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30657587

RESUMEN

OBJECTIVE: the role of microbes and chronic inflammation in the pathogenesis of Alzheimer' disease (AD) has been postulated by many authors. On the other hand, several studies have reported the main role of H. pylori infection and/or GUT microbiota alteration in promoting chronic inflammation, thus possibly influencing both occurrence and evolution of AD. In this article, we analyze the most important and recent studies performed on this field both on humans and animals and provide possible pathogenic explanations. RESULTS: all main and most recent animal, human, epidemiological and in-silico studies, showed a role of H. pylori and/or dysbiosis in AD, mostly through the promotion of systemic chronic inflammation and/or by triggering molecular mimicry mechanisms. In particular, H. pylori infection seems to be related to a poorer cognitive performance. CONCLUSIONS: Indeed, bacteria have been shown to affect neurodegeneration by promoting inflammation, inducing molecular mimicry mechanisms and accumulation of Aß into the brain. These findings open the way for H. pylori eradicating trials and/or GUT microbiota remodulating strategies. Therefore, further studies are now needed in order to test whether antibiotics, pre and/or probiotics may exert a beneficial effect in the prevention of AD.


Asunto(s)
Enfermedad de Alzheimer/inmunología , Encéfalo/patología , Disbiosis/inmunología , Microbioma Gastrointestinal/inmunología , Infecciones por Helicobacter/inmunología , Enfermedad de Alzheimer/microbiología , Enfermedad de Alzheimer/patología , Enfermedad de Alzheimer/prevención & control , Péptidos beta-Amiloides/inmunología , Péptidos beta-Amiloides/metabolismo , Animales , Antibacterianos/administración & dosificación , Encéfalo/inmunología , Cognición , Modelos Animales de Enfermedad , Disbiosis/complicaciones , Disbiosis/tratamiento farmacológico , Disbiosis/microbiología , Microbioma Gastrointestinal/efectos de los fármacos , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/microbiología , Helicobacter pylori/inmunología , Helicobacter pylori/aislamiento & purificación , Humanos , Imitación Molecular/inmunología , Probióticos/administración & dosificación
5.
High Blood Press Cardiovasc Prev ; 25(2): 209-218, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29582365

RESUMEN

INTRODUCTION: Recently new treatment options have substantially increased survival for patients with relapsed and/or refractory multiple myeloma (RRMM). Among these, proteasome inhibitors (PI), such as bortezomib and carfilzomib, offer high response rate and prolonged survival. These agents are generally well tolerated but demonstrated a significant cardiovascular toxicity, mostly for regimen containing carfilzomib. AIM: To assess the cardiovascular damage in patients treated with PI for RRMM. METHODS: 28 consecutive subjects treated with PI for RRMM were evaluated and compared with a population of 22 control (Con) subjects, matched for age, sex and mean 24 h blood pressure (24hMBP). All individuals underwent trans-thoracic echocardiography, ambulatory blood pressure monitoring and pulse wave velocity (PVW) study. RESULTS: PI patients did not have significant differences in blood pressure load and PWV compared to controls. Among echocardiographic parameters, the global longitudinal strain (GLS) was significantly decreased in PI subjects (p = 0.02). The GLS was significantly lower also considering only patients treated with carfilzomib. Moreover, among carfilzomib patients, we found increase values of left ventricle mass indexed by BSA (LVMi; p = 0.047). After correction for age, sex, BSA, 24hMBP and morphological and functional parameters of LV, treatment with PI and carfilzomib were significantly associated with GLS (p = 0.01; p = 0.036, respectively). CONCLUSIONS: PI treatment is associated with subclinical LV dysfunction in patients with RRMM compared to controls, as demonstrated by lower GLS values. These results are confirmed also considering patients treated with carfilzomib. Moreover, in this subgroup of patients, the LVMi is also increased, suggesting higher cardiotoxicity with this treatment.


Asunto(s)
Antineoplásicos/efectos adversos , Mieloma Múltiple/tratamiento farmacológico , Oligopéptidos/efectos adversos , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Inhibidores de Proteasoma/efectos adversos , Disfunción Ventricular Izquierda/inducido químicamente , Anciano , Enfermedades Asintomáticas , Bortezomib/efectos adversos , Cardiotoxicidad , Estudios de Casos y Controles , Ecocardiografía Doppler , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mieloma Múltiple/diagnóstico , Mieloma Múltiple/enzimología , Complejo de la Endopetidasa Proteasomal/metabolismo , Factores de Riesgo , Resultado del Tratamiento , Disfunción Ventricular Izquierda/diagnóstico por imagen , Disfunción Ventricular Izquierda/fisiopatología , Función Ventricular Izquierda/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda